Keybank National Association OH Has $21.14 Million Stock Holdings in Aflac Incorporated (NYSE:AFL)

Keybank National Association OH decreased its holdings in shares of Aflac Incorporated (NYSE:AFL) by 0.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 204,360 shares of the financial services provider’s stock after selling 1,004 shares during the quarter. Keybank National Association OH’s holdings in Aflac were worth $21,139,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in AFL. Whipplewood Advisors LLC bought a new stake in Aflac in the fourth quarter valued at about $26,000. Darwin Wealth Management LLC bought a new position in Aflac during the third quarter worth about $34,000. BankPlus Trust Department acquired a new position in shares of Aflac during the 4th quarter worth about $34,000. Raelipskie Partnership bought a new stake in shares of Aflac in the 3rd quarter valued at about $38,000. Finally, Covestor Ltd raised its position in shares of Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after acquiring an additional 107 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Keefe, Bruyette & Woods decreased their price objective on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a report on Wednesday, February 12th. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Piper Sandler dropped their price objective on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research note on Friday, February 7th. Wells Fargo & Company decreased their target price on Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 19th. Finally, Morgan Stanley increased their price target on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $103.36.

Aflac Trading Down 2.3 %

Shares of Aflac stock opened at $107.56 on Wednesday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The firm has a 50-day moving average of $104.79 and a 200-day moving average of $107.67. Aflac Incorporated has a 52-week low of $79.22 and a 52-week high of $115.50. The stock has a market cap of $58.79 billion, a PE ratio of 11.20, a PEG ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, sell-side analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.

Insider Buying and Selling

In related news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the sale, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.90% of the stock is currently owned by company insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.